Logo image of MSON

Misonix Inc (MSON) Stock Fundamental Analysis

NASDAQ:MSON - Nasdaq -

26.54  +1.2 (+4.74%)

After market: 26.54 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MSON. MSON was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MSON have multiple concerns. While showing a medium growth rate, MSON is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year MSON has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -7.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -14.91%
PM (TTM) -19.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

There is no outstanding debt for MSON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

MSON has an Altman-Z score of 4.27. This indicates that MSON is financially healthy and has little risk of bankruptcy at the moment.
MSON has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 4.27
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.61 indicates that MSON has no problem at all paying its short term obligations.
A Quick Ratio of 1.92 indicates that MSON should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 1.92

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.00% over the past year.
MSON shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.47%.
The Revenue has been growing by 26.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y26.37%
Revenue growth 5Y26.21%
Sales Q2Q%43.55%

3.2 Future

MSON is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.37% yearly.
Based on estimates for the next years, MSON will show a quite strong growth in Revenue. The Revenue will grow by 15.97% on average per year.
EPS Next Y10.14%
EPS Next 2Y25.01%
EPS Next 3Y13.04%
EPS Next 5Y6.37%
Revenue Next Year16.14%
Revenue Next 2Y16.55%
Revenue Next 3Y15.78%
Revenue Next 5Y15.97%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MSON Yearly Revenue VS EstimatesMSON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MSON Yearly EPS VS EstimatesMSON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSON. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MSON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MSON Price Earnings VS Forward Price EarningsMSON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -80.24
MSON Per share dataMSON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as MSON's earnings are expected to grow with 13.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.01%
EPS Next 3Y13.04%

0

5. Dividend

5.1 Amount

MSON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Misonix Inc

NASDAQ:MSON (10/28/2021, 8:55:53 PM)

After market: 26.54 0 (0%)

26.54

+1.2 (+4.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-11 2022-02-11/amc
Inst Owners0%
Inst Owner Change-97.67%
Ins Owners7.59%
Ins Owner Change0%
Market Cap462.06M
Analysts60
Price Target28.56 (7.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.24
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB N/A
EV/EBITDA -80.24
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.25
BVpS7.77
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.91%
PM (TTM) -19.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.61
Quick Ratio 1.92
Altman-Z 4.27
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
EPS Next Y10.14%
EPS Next 2Y25.01%
EPS Next 3Y13.04%
EPS Next 5Y6.37%
Revenue 1Y (TTM)18.47%
Revenue growth 3Y26.37%
Revenue growth 5Y26.21%
Sales Q2Q%43.55%
Revenue Next Year16.14%
Revenue Next 2Y16.55%
Revenue Next 3Y15.78%
Revenue Next 5Y15.97%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A